Steele Glenn Jr Md Phd sold 12,000 shares of PTC THERAPEUTICS, INC. at $65.16 for −$782k on Sep 30, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$781,920Shares × reported price
Shares traded
12,000Common Stock
Price per share
$65.16Reported price. Read footnotes for ranges.
% of reported position traded
34.78%This security and ownership context
Holdings after
22,500Direct
Trade date
Sep 30, 2026Sell
Filed
Oct 2, 2026, 5:20 PM ET2-day reporting delay
Accession
0001269131-26-000005Code S · Transaction 235466
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 34,500 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 30, 2026Option exercise12,000$11.23$134,760Trade 235465
Sep 30, 2026Option exercise12,000$0.00$0Trade 235467
3 transaction rows in this filing. Joint filers share the same rows.

PTCT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PTCT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +9.6%1w ago −1.8%1d ago +2.4%
Returns since7d +2%30d −5.5%90d180d1y

Footnotes in full

F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 9, 2026 F2: Currently exercisable.